title: Persistence of BCR/ABL transcripts after BMT for CML detected by PCR reflects a high risk of relapse.
authors.affiliation: Royal Postgraduate Medical School, London, UK.
authors.forename: T P
authors.initials: TP
authors.lastname: Hughes
authors.forename: P
authors.initials: P
authors.lastname: O'Shea
authors.forename: G
authors.initials: G
authors.lastname: Morgan
authors.forename: P
authors.initials: P
authors.lastname: Martiat
authors.forename: J M
authors.initials: JM
authors.lastname: Goldman
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D016026:Bone Marrow Transplantation; D005500:Follow-Up Studies; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D016133:Polymerase Chain Reaction; D011379:Prognosis; D012333:RNA, Messenger / Q000032:analysis*; D012334:RNA, Neoplasm / Q000032:analysis*; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D016044:Fusion Proteins, bcr-abl